Contact
Nicole Schneider
The pathophysiological understanding of interstitial lung diseases (ILDs) has made impressive progress over the last years leading to approved therapies and an increasing number of promising drug candidates currently tested in clinical trials. In our online seminar, an interdisplinary panel of leaders in the field will present their novel data on target identification, large scale tissue omics and image omics in the ILDs.
Online
03.02.2022
16.00 - 18.00 CEST
| 16.oo h | Welcome Oliver Distler, Zurich, Switzerland |
|---|---|
| 16.05 h | Target identification and drug discovery in pulmonary fibrosis Melanie Königshoff, Division of Pulmonary, Allergologoy and Critical Care Medicine, University of Pittsburgh, USA |
| 16.40 h | Pathophysiology of Pulmonary Fibrosis – Lessons from the Human Lung Naftali Kaminski, Pulmonary Critical Care and Sleep Medicine, Yale School of Medicine, USA |
| 17.15 h | Application of Image-Omics in Interstitial Lung Diseases Janine Schniering, Helmholtz Munich, German Research Center for Environmental Health, Neuherberg, D |
| 17.50 h | Summary and conclusion Oliver Distler, Zurich, Switzerland |
Meeting-ID: 613 9961 2747
Kenncode: 210976